Work

First-line use of EGFR tyrosine kinase inhibitors in patients with NSCLC containing EGFR mutations.

Year: 2010

Type: article

Source: PubMed

Authors: Joel W Neal, Lecia V Sequist

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W47254371

FWCI: 2.952

Cites: 68

Cited by: 17

Related to: 20